Editor's Note
Surgisphere Corporation (Palatine, Illinois) on March 12 announced the availability of its new rapid diagnostic test for COVID-19 that uses artificial intelligence (AI).
With advanced machine learning, Surgisphere has developed an intelligent tool that uses three common lab tests to identify patients likely to have COVID-19 infection.
With its cloud-based healthcare data analytics platform (QuartzClinical), Surgisphere identified patients diagnosed with COVID-19 in five countries. The company then created a machine learning model using decision tree analysis and clinical and lab data on 430 patients to develop the decision support tool.
The test is now available for public use.
Read More >>What happens when a veteran perioperative leader walks away from…
The migration of surgical cases from inpatient settings to ambulatory…
In perioperative care, high-performing teams are critical to patient safety…